1. Aggressive variants of follicular cell-derived thyroid carcinoma: an overview

   • Cristina Pizzimenti
   • Vincenzo Fiorentino
   • Guido Fadda

   Review 21 July 2022 Pages: 1 - 12

2. Intensive vs. conventional blood pressure goals in older patients with type 2 diabetes: a systematic review and meta-analysis

   • Rene Rodriguez-Gutierrez
   • Andrea Flores-Rodríguez
   • Jose G. Gonzalez-Gonzalez

   Meta-Analysis 13 August 2022 Pages: 13 - 23

   

3. Operation rate and cancer prevalence among thyroid nodules with FNAC report of suspicious for malignancy (TIR4) or malignant (TIR5) according to Italian classification system: a systematic review and meta-analysis

   • Pierpaolo Trimboli
   • Giulia Ferrarazzo
   • Cosimo Durante

   Meta-Analysis Open access 20 August 2022 Pages: 24 - 31

   

4. Estrogen promotes fetal skeletal muscle myofiber development important for insulin sensitivity in offspring

   • Soon Ok Kim
   • Eugene D. Albrecht
   • Gerald J. Pepe

   Original Article 17 June 2022 Pages: 32 - 41

   

5. Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination

   • Berna İmge Aydoğan
   • Uğur Ünlütürk
   • Mustafa Cesur

   Original Article 09 July 2022 Pages: 42 - 46

6. Early-onset diabetes involving three consecutive generations had different clinical features from age-matched type 2 diabetes without a family history in China

   • Da-Wei Wang
   • Jing Yuan
   • Jin-Kui Yang

   Original Article Open access 03 August 2022 Pages: 47 - 56

   

7. Dietary patterns are associated with arterial stiffness and carotid atherosclerosis in postmenopausal women

   • Iliana Karagkouni
   • Dimitris Delialis
   • Irene Lambrinoudaki

   Original Article 29 August 2022 Pages: 57 - 67

8. Antitumour effects of apatinib in progressive, metastatic differentiated thyroid cancer (DTC)

   • Liang Shi
   • Qinqin You
   • Shuren Li

   Original Article Open access 29 June 2022 Pages: 68 - 76

   

9. Successful dose escalation of lenvatinib for thyroid cancer after disease progression

   • Chie Masaki
   • Kiminori Sugino
   • Koichi Ito

   Original Article 23 June 2022 Pages: 77 - 84

   

10. ACLY inhibitors induce apoptosis and potentiate cytotoxic effects of sorafenib in thyroid cancer cells

    • Shou-Sen Huang
    • Chung-Hsin Tsai
    • Shih-Ping Cheng

    Original Article 27 June 2022 Pages: 85 - 94

    

11. Diagnostic and prognostic value of Stanniocalcin 1 expression in papillary thyroid cancer

    • Sevinç Sengun
    • Hakan Korkmaz
    • Mehmet Kiran

    Original Article 04 July 2022 Pages: 95 - 103

    

12. Assessment of age as different variable types for determining survival in differentiated thyroid cancer

    • Li Genpeng
    • Shao Yuting
    • Lei Jianyong

    Original Article 03 August 2022 Pages: 104 - 113

    

13. A noninvasive scoring model for the differential diagnosis of ACTH-dependent Cushing’s syndrome: a retrospective analysis of 311 patients based on easy-to-use parameters

    • Xiaohong Lyu
    • Dingyue Zhang
    • Lin Lu

    Original Article 04 August 2022 Pages: 114 - 122

    

14. Long-term outcomes in patients with adult-onset craniopharyngioma

    • Prerna Dogra
    • Lucia Bedatsova
    • Dana Erickson

    Original Article 23 July 2022 Pages: 123 - 134

    

15. Cardiometabolic profile of young women with hypoprolactinemia

    • Robert Krysiak
    • Karolina Kowalcze
    • Bogusław Okopień

    Original Article Open access 29 July 2022 Pages: 135 - 141

16. Adrenalectomy improves blood pressure control in nonfunctioning adrenal incidentalomas and glycemic and lipid control in patients with autonomous cortisol secretion

    • Marta Araujo-Castro
    • César Mínguez Ojeda
    • María Fernández-Argüeso

    Original Article 25 June 2022 Pages: 142 - 150

    

17. Actual prevalence of hypoparathyroidism after total thyroidectomy: a health insurance claims-database study

    • Takeshi Takahashi
    • Keisuke Yamazaki
    • Arata Horii

    Original Article 01 August 2022 Pages: 151 - 158

    

18. Bcl-2 and Noxa are potential prognostic indicators for patients with gastroenteropancreatic neuroendocrine neoplasms

    • Yu Guo
    • Lin Zhang
    • Jie Chen

    Original Article 27 July 2022 Pages: 159 - 168

    

19. Somatostatin receptor-directed molecular imaging for therapeutic decision-making in patients with medullary thyroid carcinoma

    • Sebastian E. Serfling
    • Yingjun Zhi
    • Rudolf A. Werner

    Original Article Open access 25 June 2022 Pages: 169 - 176

    

20. Neutrophil to lymphocyte ratio as a prognosis biomarker of PRRT in NET patients

    • Beatriz Arruda Matheos de Lima
    • Rinaldo Gonçalves da Silva
    • Daniel Bulzico

    Original Article 13 July 2022 Pages: 177 - 185

    

21. Endoscopic surveillance alone is feasible and safe in type I gastric neuroendocrine neoplasms less than 10 mm in diameter

    • Klaire Exarchou
    • Haiyi Hu
    • D. Mark Pritchard

    Original Article Open access 27 July 2022 Pages: 186 - 196

    

22. Lenvatinib-induced hypocalcaemia due to transient primary hypoparathyroidism

    • Matteo Trevisan
    • Carla Colombo
    • Simone De Leo

    Brief report 20 July 2022 Pages: 197 - 200

    

23. Unilateral or bilateral adrenalectomy in PPNAD: six cases from a single family followed up over 40 years

    • G. Vitellius
    • B. Donadille
    • B. Delemer

    Brief report 04 August 2022 Pages: 201 - 204